GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
88 hedge funds and large institutions have $345M invested in GenMark Diagnostics, Inc in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
-1
Holders Change %
-1.12%
% of All Funds
2.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
39
Reduced
26
Closed
9
Calls
$1K
Puts
$272K
Net Calls
-$271K
Net Calls Change
-$289K
Top Buyers
| 1 |
CCM
Cadian Capital Management
New York
|
+$9.75M |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$9.57M |
| 3 |
VAM
Visium Asset Management
New York
|
+$2.46M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.97M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$963K |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$6.89M |
| 2 |
FAM
Fred Alger Management
New York
|
-$3.2M |
| 3 |
Parnassus Investments
San Francisco,
California
|
-$2.55M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$2.31M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$1.97M |
